About Cambridge Cognition
Cambridge Cognition is a publicly listed company based in Cambridge (United Kingdom) founded in 2002. Computerized neuropsychological tests are offered for cognitive assessment. Cambridge Cognition has completed 2 acquisitions, including Clinpal and Winterlight Labs. Its website cambridgecognition.com draws about 70 thousand monthly visits. Cambridge Cognition offers products and services including CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralized Clinical Trials. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is CAMBRIDGE COGNITION LIMITED.
Company details
Computerized neuropsychological tests for cognitive assessment are provided by Cambridge Cognition, founded in 2002 in Cambridge, United Kingdom. Operations center on tools that aid diagnosis and treatment of neurological and psychiatric disorders. CANTAB Mobile serves as a screening application for early memory impairment linked to Alzheimers disease. CANTAB Insight evaluates brain function across cognitive domains, while CANTAB Recruit functions as an online platform for identifying clinical trial participants.
- Headquarters Cambridge, United Kingdom
- Stage Public
- SectorsHealthcare
- Website category Health · Mental Health
- Email••••••••
- Phone•••• ••••
- Website cambridgecognition.com
- Social LinkedIn X Facebook
- Legal Name Cambridge Cognition Holdings Plc
- Annual Revenue$12.66 M (USD)-9.11as on Dec 31, 2025
- Net Profit-$2.26 M (USD)6.16as on Dec 31, 2025
- EBITDA-$1.01 M (USD)-4.45as on Dec 31, 2025
- Latest Funding Round$3.27M (USD), Post-IPO
Mar 2019
- Investments & AcquisitionsClinpal
& 1 more
Products & Services of Cambridge Cognition
Cambridge Cognition offers a comprehensive portfolio of products and services, including CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralized Clinical Trials.
Digital tool for sensitive cognitive evaluations in clinical trials.
Automated system for scoring verbal cognitive tests accurately.
Platform for digital administration of research questionnaires.
Tasks for regular cognitive function tracking in studies.
End-to-end platform for remote trial data collection.
Funding Insights of Cambridge Cognition
- Total Rounds 1
- Last Round Post-IPO — $3.27M
- First Round $3.27M
(Mar 2019)
All 1 funding rounds of Cambridge Cognition with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | $3.27M | Post-IPO | – | – | – |
IPO & Listings of Cambridge Cognition
Cambridge Cognition is a publicly listed company on the LSE with ticker symbol COG in UK, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Apr 2013
- Listed onLSE: COG
- Listed entityCambridge Cognition Holdings Plc
- Exchange sectorTechnology services
- ISINGB00B8DV9647
- Share price29.00 GBX (+3.57% on the day) · 2026-10-14
- Market capitalisation15,109,476.00 GBX
- EPS (diluted, trailing year)-0.03 GBX
- Volume (last session)10
Financials of Cambridge Cognition
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 9.4M GBP | -1.7M GBP | -751,000 GBP |
| 2024 | 10.3M GBP | -1.8M GBP | -719,000 GBP |
| 2023 | 13.5M GBP | -3.5M GBP | -1.5M GBP |
| 2022 | 12.6M GBP | -409,000 GBP | -842,000 GBP |
| 2021 | 10.1M GBP | 450,000 GBP | 696,000 GBP |
Detailed financial statements for Cambridge Cognition
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cambridge Cognition
Cambridge Cognition has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Clinpal and Winterlight Labs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cognitive impairment signs are detected through speech sample analysis. | winterlightlabs.com | Toronto, Canada | 2015 | Jan 2023 | $8.51M | |
Technology and consulting for clinical trials industry are provided. | clinpal.com | Stirling, United Kingdom | 2012 | Oct 2022 | •••• |
Complete acquisition details for Cambridge Cognition
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cambridge Cognition
5 dated milestones of Cambridge Cognition across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Cambridge Cognition is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $3.3M.
- Acquisition Acquires Clinpal.
- Acquisition Acquires Winterlight Labs.
Web traffic of Cambridge Cognition
The website of Cambridge Cognition (cambridgecognition.com) receives about 70.3K visits a month and ranks #565,530 among all websites worldwide, #874 in Mental Health.
- Monthly visits70.3K
▲ 19.4% vs previous month
- Unique visitors23.9K
per month
- Global rank#565,530
among all websites
- Category rank#874
Health · Mental Health
- Bounce rate43%
- Pages per visit2.2
- Average visit1 min 06 sec
- DevicesDesktop 32% · Mobile 68%
Websites whose visitors overlap most with Cambridge Cognition. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
memorylosstest.com | memorylosstest.com | 100% | #515,179 | – | |
| creyos.com | 84% | 112.4K | #308,474 | View details | |
iqout.com | iqout.com | 84% | – | ||
cogtest.com | cogtest.com | 80% | – | ||
| mybraintrainer.com | 76% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Cambridge Cognition
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cambridge Cognition
Complete news archive for Cambridge Cognition
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cambridge Cognition
Cambridge Cognition was founded in 2002 and raised its 1st funding round 17 years after it was founded.
Cambridge Cognition is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Annual revenue of Cambridge Cognition is $12.66M as on Dec 31, 2025.
Computerized neuropsychological tests for cognitive assessment are provided by Cambridge Cognition, founded in 2002 in Cambridge, United Kingdom. Operations center on tools that aid diagnosis and treatment of neurological and psychiatric disorders. CANTAB Mobile serves as a screening application for early memory impairment linked to Alzheimers disease. CANTAB Insight evaluates brain function across cognitive domains, while CANTAB Recruit functions as an online platform for identifying clinical trial participants.
Cambridge Cognition offers CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralized Clinical Trials.
Yes, Cambridge Cognition is publicly traded on LSE under the ticker symbol COG.
Cambridge Cognition has made 2 acquisitions, including Clinpal, and Winterlight Labs.
Cambridge Cognition operates through Cambridge Cognition Limited.